BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30857342)

  • 1. Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies.
    Sonbol MB; Ahn DH; Bekaii-Saab T
    Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30857342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells in gastrointestinal cancers: The road less travelled.
    Mikhail S; Zeidan A
    World J Stem Cells; 2014 Nov; 6(5):606-13. PubMed ID: 25426257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.
    Huang TX; Guan XY; Fu L
    Am J Cancer Res; 2019; 9(9):1889-1904. PubMed ID: 31598393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.
    Pádua D; Figueira P; Ribeiro I; Almeida R; Mesquita P
    Front Cell Dev Biol; 2020; 8():442. PubMed ID: 32626705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.
    Koury J; Zhong L; Hao J
    Stem Cells Int; 2017; 2017():2925869. PubMed ID: 28356914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
    Mudra SE; Sadhukhan P; Ugurlu MT; Alam S; Hoque MO
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, Culture and Targeting of Cancer Stem Cells.
    Herreros-Pomares A
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
    Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
    J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.